Adrenocortical neoplasms in young children: Age as a prognostic factor

Annals of Clinical and Laboratory Science

Volumn 39, Issue 3, 2009, Pages 277-282

  Ahmed, Atif Ali ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Adrenocortical tumors; Ki 67; p53; Pediatric oncology

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; TESTOSTERONE;

ADRENAL CORTEX TUMOR; ADRENAL GLAND; ADRENALECTOMY; ANAMNESIS; ARTICLE; CANCER INVASION; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LABORATORY TEST; MALE; MITOSIS RATE; NECROSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; TESTOSTERONE BLOOD LEVEL; TUMOR VOLUME; VIRILIZATION;

ADRENAL CORTEX NEOPLASMS; AGE FACTORS; CHILD, PRESCHOOL; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; INFANT; KI-67 ANTIGEN; MALE; PROGNOSIS; TESTOSTERONE; TUMOR SUPPRESSOR PROTEIN P53; VIRILISM;

EID: 68949154547     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Agrons GA, Lonergran GJ, Dickey GE, Perez-Monte JE. Adrenocortical neoplasms in children: Radiologic-pathologic correlation. Radiographics 1999;19:989-1008.
2. Ribeiro RC, Michalikiewicz E, Figueiredo BC, Delacerda L, Sandrini F, Pianovsky MD, Sampaio G, Sandrini R. Adrenocortical tumors in children. Brazil J Med Biol Res 2000;33:1225-1234.
3. Michalkiewicz E, Sandrini R, Figueiredo B, Miranda ECM, Caran E, Oliveira-Filho AG, Marques R, Pianovski MAD, Lacerda L, Cristofani LM, Jenkins J, Rodriguez-Galindo, Ribeiro RC. Clinical and outcome characteristics of children with adrenocortical tumors: A report from the international pediatric adrenocortical tumor registry. J Clin Oncol 2004;22:838-845. (Pubitemid 41103595)
4. Patil KK, Ransley PG, Mccullagh M, Malone M, Spitz L. Functioning adrenocortical neoplasms in children. BJU International 2002;89:562-565.
5. Bonfig W, Bittmann I, Bechtfold S, Kammer B, Noelle V, Arleth S, Raile K, Schwarz HP. Virilizing adrenocortical tumours in children. Eur J Pediatr 2003;162:623-628.
6. Soon PH, Mcdonald KI, Robinson BG, Sidhu SB. Molecular markers and the pathogenesis of adrenocortical cancer. Oncologist 2008;13:548-561. (Pubitemid 351872872)
7. Libe R, Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur J Endocrinol 2005;153 477-487. (Pubitemid 41568145)
8. Sutter JA, Grimberg A. Adrenocortical tumors and hyperplasias in childhood-etiology, genetics, clinical presentation and therapy. Pediatr Endocrinol Rev 2006;4:32-39. (Pubitemid 44519170)
9. Weiss LM. Comparative histologic study of 43 metastasizing and non-metastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163-169.
10. Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989;13:202-206. (Pubitemid 19081702)
11. Wienecke JA, Thompson LD, Heffess CS. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Path 2003;27:867-881.
12. Lack EE. Tumors of the adrenal gland and extradrenal paraganglia. Atlas of Tumor Pathology, Series IV. Armed Forces Institute of Pathology, Washington, DC, 2005; pp 161-179.
13. Stojadinovic A, Ghossein RA, Hoos A, Nissan A, Marshall D, Dudas M, Cordon-Cardo C, Jaques DP, Brennan MF. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 2002;20:941-950. (Pubitemid 34141836)
14. Schmitt A, Saremaslani P, Schmid S, Rousson V, Montani M, Schmid DM, Heitz PU, Komminoth P, Perren A. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours. Histopathology 2006;46:298-307. (Pubitemid 44253620)
15. Morimoto R, Satoh F, Murakami O, Suzuki T, Abe T, Tanemoto M, Uruno A, Ishidoya S, Arai Y, Takahashi K, Sasano H, Ito S. Immunohistochemsitry of a proliferation marker Ki-67-MIB1 in adrenocortical carcinomas: Ki-67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocr J 2008;55:49-55.
16. Martins AC, Cologna AJ, Tucci S Jr, Suaid HJ, Falconi RA. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms. J Urol 2005;173:2138-2142.
17. Advani A, Vaikkakara S, Gill MS, Arun CS, Pearce SH, Ball SG, James RA, Lennard TW, Bliss RD, Quinton R, Johnson SJ. Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review. J Clin Pathol 2008;61:939-944.
18. Sbragia L, Oliveira-Filho AG, Vassallo J, Guerra-Junior GG, Bustorff-Silva J. Adrenocortical tumors in Brazilian children. Immunohistochemical markers and prognostic factors. Arch Pathol Lab Med 2005;129:1127-1131.
19. Godil MA, Atlas MP, Parker RI, Priebe CJ, Zerah MM, Kane P, Tsung J, Wilson TA. Metastatic congenital adrenocortical carcinoma: A case report with tumor remission at 3 1/2 years. J Clin Endocrinol Metab 2000;85:3964-3967. (Pubitemid 32055333)
20. Kakkar N, Vasishta RK, Lamba A, Trehan A, Marwaha RK. Pathologic case of the month. Arch Pediatr Adolesc Med 2000;154:1267-1278.
21. Sabbaga CC, Avilla SG, Schulz C, Garbers JC, Blucher D. Adrenocortical carcinoma in children: clinical aspects and prognosis. J Pediatr Surg 1993;28:841-843. (Pubitemid 23176047)